Description of Research Group:Hailong Wang group currently has 1 professor, 1 associate researcher, 3 postdoctoral fellows, 8 doctoral students, and 6 master's students. We are committed to the study of microbial gene editing and drug synthetic biology, including the development of microbial gene editing technology and its application in drug development research such as natural products biosynthesis, bacteriophage engineering, viral vector vaccines, and tumor targeted therapy. Hailong Wang group has published research papers as the first or corresponding author mainly in Nature Protocols (2), Nuclear Acids Research (3), Trends in Biotechnology, Journal of Advanced Research, Microbial Cell Factories, Analytical Chemistry, ACS Synthetic Biology, etc.